Literature DB >> 15541906

Investigation of intestinal absorption and disposition of green tea catechins by Caco-2 monolayer model.

Li Zhang1, Ying Zheng, Moses S S Chow, Zhong Zuo.   

Abstract

The current study was designed to investigate the absorption mechanism and identify the possible disposition pathways of green tea catechins (GTC), including epicatechin (EC), epigallocatechin (EGC), epicatechin gallate (ECG) and epigallocatechin gallate (EGCG), during their absorption across small intestine by Caco-2 monolayer model. The transport of each GTC from both apical to basolateral and basolateral to apical directions was measured in the absence and the presence of MK571, an MRP inhibitor. HPLC and LC/MS were employed to identify the possible metabolites of the four GTC formed during their bidirectional transport processes. The results indicated that the four GTC showed limited transepithelial absorption with relatively small P(app) values. However, significant efflux mediated by MRP was observed during the secretion of GTC, especially the non-gallated catechins. Methylation and sulfation were the main biotransformation pathways of GTC during their secretion transport and the efflux of the related metabolites seem to be mediated by MRP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15541906     DOI: 10.1016/j.ijpharm.2004.08.020

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  31 in total

1.  Role of intestinal first-pass metabolism of baicalein in its absorption process.

Authors:  Li Zhang; Ge Lin; Qi Chang; Zhong Zuo
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

Review 2.  Altered Transport and Metabolism of Phenolic Compounds in Obesity and Diabetes: Implications for Functional Food Development and Assessment.

Authors:  Benjamin W Redan; Kimberly K Buhman; Janet A Novotny; Mario G Ferruzzi
Journal:  Adv Nutr       Date:  2016-11-15       Impact factor: 8.701

3.  An Agent-Based Approach to Dynamically Represent the Pharmacokinetic Properties of Baicalein.

Authors:  Xiao Zhu; Jianyuan Deng; Zhong Zuo; Tai Ning Lam
Journal:  AAPS J       Date:  2016-08-01       Impact factor: 4.009

4.  Lack of pharmacokinetic interaction between fluvastatin and green tea in healthy volunteers.

Authors:  Shingen Misaka; Osamu Abe; Hideyuki Sato; Tomoyuki Ono; Yayoi Shikama; Satomi Onoue; Hirooki Yabe; Junko Kimura
Journal:  Eur J Clin Pharmacol       Date:  2018-01-24       Impact factor: 2.953

5.  Tea catechin auto-oxidation dimers are accumulated and retained by Caco-2 human intestinal cells.

Authors:  Andrew P Neilson; Brian J Song; Teryn N Sapper; Joshua A Bomser; Mario G Ferruzzi
Journal:  Nutr Res       Date:  2010-05       Impact factor: 3.315

6.  Encapsulation of epigallocatechin-3-gallate into albumin nanoparticles improves pharmacokinetic and bioavailability in rat model.

Authors:  Nithya Ramesh; Abul Kalam Azad Mandal
Journal:  3 Biotech       Date:  2019-05-28       Impact factor: 2.406

Review 7.  Green tea polyphenols for prostate cancer chemoprevention: a translational perspective.

Authors:  J J Johnson; H H Bailey; H Mukhtar
Journal:  Phytomedicine       Date:  2010-01       Impact factor: 5.340

8.  Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease.

Authors:  Adam Smith; Brian Giunta; Paula C Bickford; Michael Fountain; Jun Tan; R Douglas Shytle
Journal:  Int J Pharm       Date:  2010-01-18       Impact factor: 5.875

9.  Utilization of gene expression signature for quality control of traditional Chinese medicine formula Si-Wu-Tang.

Authors:  Chen Xie; Zhijun Wang; Charles Wang; Jun Xu; Zhining Wen; Haitian Wang; Leming Shi; Moses S S Chow; Ying Huang; Zhong Zuo
Journal:  AAPS J       Date:  2013-05-24       Impact factor: 4.009

10.  Effect of genistein on the bioavailability and intestinal cancer chemopreventive activity of (-)-epigallocatechin-3-gallate.

Authors:  Joshua D Lambert; Seok-Joo Kwon; Jihyeung Ju; Mousumi Bose; Mao-Jung Lee; Jungil Hong; Xingpei Hao; Chung S Yang
Journal:  Carcinogenesis       Date:  2008-08-05       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.